How long should children with spasticity take Vigabatrin (vigabatrin)?

Vigabatrin (Vigabatrin) is an anti-epileptic drug commonly used to treat spasms in infants (Infantile spasms, IS). Vigabatrin is often used as a first-line treatment for pediatric patients with spasticity associated with tuberous sclerosis. Generally speaking, the treatment time of Vigabatrin depends on the child's response to the drug and the control of epilepsy. There is no uniform fixed course of treatment, and it usually needs to be taken continuously for several months or even longer.

In clinical practice, if a child's spasms are significantly reduced or disappeared within a few weeks to two months after starting to use Vigabatrin, doctors usually recommend continuing the treatment for a period of time to consolidate the effect. After initially controlling symptoms, many patients will gradually reduce the dosage according to the stability of their condition, and eventually stop taking the medicine under the guidance of a doctor. However, if the symptom control is not satisfactory, the treatment time may need to be extended, and the need to adjust the treatment plan or combine it with other drugs will be evaluated.

Since long-term use of Vigabatrin may have certain side effects, especially the risk of visual field loss, doctors will closely monitor the child's vision and other health indicators during the treatment process. Therefore, while using Vigabatrin, parents need to take their children for regular follow-up visits and cooperate with relevant examinations to ensure that drug treatment is both effective and safe. When you find any discomfort, you should communicate with the doctor in time to avoid side effects that may affect the child's health.

In general, the treatment time of Vigabatrin for children with spasticity is individualized and needs to be flexibly adjusted according to changes in the condition. Parents should strictly follow the doctor's medication instructions during treatment and are not allowed to stop medication or change the dosage on their own. Through standardized medication and close observation, the therapeutic effect of Vigabatrin can be maximized, helping children control spasms and improving prognosis.

Reference materials:https://www.sabril.net/